Biotage logo

Biotage

Stock
Stock
ISIN: SE0000454746
Ticker: BIOT
SE0000454746
BIOT

Price

Price

CHART BY

Historical dividends and forecast

 


0.114

CHART BY

Frequently asked questions

Biotage's Earnings Per Share (EPS) over the trailing twelve months (TTM) is 0.323. EPS indicates the company's profitability on a per-share basis.
Currently, 1 analysts cover Biotage's stock, with a consensus target price of $14.63. Analyst ratings provide insights into the stock's expected performance.
Over the trailing twelve months, Biotage reported a revenue of $197.91M.
Biotage's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $47.13M. EBITDA measures the company's overall financial performance.
Biotage has a free cash flow of $26.64M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
Biotage employs approximately 673 people. It operates in the Health Care sector, specifically within the Medical Specialties industry.

Financials

EPS (TTM) 
0.323
Revenue (TTM) 
$197.91M
EBITDA (TTM) 
$47.13M
Free Cashflow (TTM) 
$26.64M

Analyst Ratings

The price target is $14.63 and the stock is covered by 1 analysts.

Buy

0

Hold

1

Sell

0

Information

Biotage AB is a Swedish life science company specializing in advanced laboratory technologies and workflow solutions that support drug discovery, development, and analytical testing to improve human health. The company is based in Uppsala, Sweden. The company offers a comprehensive portfolio of systems, consumables, reagents, and accessories focused on chemical synthesis, purification, evaporation, and sample extraction and clean-up. Product categories include organic and peptide synthesis, biomolecule purification, flash chromatography, solid-phase and supported liquid extraction, filtration, and evaporation technologies. Biotage provides automated sample preparation workstations, advanced peptide synthesizers, specialized solid-supported reagents, chromatography resins, prepacked columns, cartridges, and plates for various purification needs. The company's solutions are used in bioanalysis, forensic toxicology, environmental testing, food safety, doping control, and biomolecule purification, and are supported by knowledge resources, customer service, application support, and software tools. The company serves customers in pharmaceutical, biotech, contract research and manufacturing, clinical, forensic, academic laboratories, and organizations focused on food safety, clean water, and environmental sustainability. and has a global presence of subsidiaries in several regions. The company was founded in 1969 by Bengt Falk, Bertil Pettersson, Björn Lennart Ekström, Carl Erik Mathias Uhlén, Mostafa Ronaghi, Neil Goldsmith, Pal Nyrén, Sheridan G. Snyder. Frederic Vanderhaegen has been the CEO of the company since 2024.

Employees
673
Industries
Medical Specialties
Sector
Health Care

Identifier

ISIN
SE0000454746
Primary Ticker
BIOT

Knockouts

Real-time data from LSX · Fundamentals & EOD data from FactSet
Join the conversation